Sylvie D Lambert1, Afaf Girgis, Christophe Lecathelinais, Fiona Stacey. 1. Translational Cancer Research Unit, Ingham Institute for Applied Medical Research, South Western Sydney Clinical School, Faculty of Medicine, The University of New South Wales, P.O. Box 3151 (Westfield), Liverpool, 2170 NSW, Australia. s.lambert@unsw.edu.au
Abstract
PURPOSE: This study aims to examine the prevalence of psychosocial variables associated with anxiety and depression among partners and caregivers of cancer survivors, compare prevalence with community norms and report differences across cancer diagnosis. METHODS: A prospective survey of partners and caregivers was undertaken to assess anxiety and depression and potential psychosocial variables associated with these outcomes at 6 and 12 months post-survivor diagnosis (N = 436). RESULTS: Although the proportion of anxious participants decreased over time (p = 0.01), the percentage of those depressed remained stable (p = 0.68). Most participants who were depressed were also anxious. To a certain extent, the prevalence of anxiety and depression exceeded community norms and varied across cancer types. Partners and caregivers particularly vulnerable included those of lung, haematological or head and neck survivors. High use of avoidant coping and interference in regular activities were associated with both anxiety and depression across time points. Of the different types of support measured, only lower emotional/informational support was associated with anxiety and depression at 6 months, whereas lower positive social interaction was associated with depression at 12 months. Additional variables associated with anxiety and depression at 12 months included higher unmet needs and involvement in personal and medical tasks, respectively. CONCLUSIONS: Even at 12 months post-survivor diagnosis, almost a third of participants reported anxiety, a result partially predicted by high use of avoidant coping and interference in regular activities. Understanding variables associated with partners' and caregivers' anxiety and depression can lead to optimal referral to supportive care services and inform the tailoring of interventions to address those variables contributing to anxiety and depression at particular time points.
PURPOSE: This study aims to examine the prevalence of psychosocial variables associated with anxiety and depression among partners and caregivers of cancer survivors, compare prevalence with community norms and report differences across cancer diagnosis. METHODS: A prospective survey of partners and caregivers was undertaken to assess anxiety and depression and potential psychosocial variables associated with these outcomes at 6 and 12 months post-survivor diagnosis (N = 436). RESULTS: Although the proportion of anxious participants decreased over time (p = 0.01), the percentage of those depressed remained stable (p = 0.68). Most participants who were depressed were also anxious. To a certain extent, the prevalence of anxiety and depression exceeded community norms and varied across cancer types. Partners and caregivers particularly vulnerable included those of lung, haematological or head and neck survivors. High use of avoidant coping and interference in regular activities were associated with both anxiety and depression across time points. Of the different types of support measured, only lower emotional/informational support was associated with anxiety and depression at 6 months, whereas lower positive social interaction was associated with depression at 12 months. Additional variables associated with anxiety and depression at 12 months included higher unmet needs and involvement in personal and medical tasks, respectively. CONCLUSIONS: Even at 12 months post-survivor diagnosis, almost a third of participants reported anxiety, a result partially predicted by high use of avoidant coping and interference in regular activities. Understanding variables associated with partners' and caregivers' anxiety and depression can lead to optimal referral to supportive care services and inform the tailoring of interventions to address those variables contributing to anxiety and depression at particular time points.
Authors: Jeremy W Couper; Sidney Bloch; Anthony Love; Gillian Duchesne; Michelle Macvean; David W Kissane Journal: Med J Aust Date: 2006-10-16 Impact factor: 7.738
Authors: Melanie A Price; Phyllis N Butow; Daniel S J Costa; Madeleine T King; Lynley J Aldridge; Joanna E Fardell; Anna DeFazio; Penelope M Webb Journal: Med J Aust Date: 2010-09-06 Impact factor: 7.738
Authors: Line Lund; Lone Ross; Morten Aagaard Petersen; Lisa Sengelov; Mogens Groenvold Journal: Support Care Cancer Date: 2019-06-08 Impact factor: 3.603
Authors: Sylvie D Lambert; Patrick McElduff; Afaf Girgis; Janelle V Levesque; Tim W Regan; Jane Turner; Hayley Candler; Cathrine Mihalopoulos; Sophy T F Shih; Karen Kayser; Peter Chong Journal: Support Care Cancer Date: 2015-07-17 Impact factor: 3.603
Authors: J Nicholas Dionne-Odom; Allison J Applebaum; Katherine A Ornstein; Andres Azuero; Paula P Warren; Richard A Taylor; Gabrielle B Rocque; Elizabeth A Kvale; Wendy Demark-Wahnefried; Maria Pisu; Edward E Partridge; Michelle Y Martin; Marie A Bakitas Journal: Psychooncology Date: 2017-12-28 Impact factor: 3.894
Authors: Kathrin Milbury; Hoda Badr; Frank Fossella; Katherine M Pisters; Cindy L Carmack Journal: Support Care Cancer Date: 2013-04-02 Impact factor: 3.603
Authors: Sylvie D Lambert; Afaf Girgis; Jane Turner; Tim Regan; Hayley Candler; Ben Britton; Suzanne Chambers; Catalina Lawsin; Karen Kayser Journal: Support Care Cancer Date: 2013-08-17 Impact factor: 3.603
Authors: Leila Heckel; Kate M Fennell; Liliana Orellana; Anna Boltong; Monica Byrnes; Patricia M Livingston Journal: Support Care Cancer Date: 2018-05-15 Impact factor: 3.603